Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06288334
Status:
RECRUITING
Last Update Posted:
2024-03-01
First Post:
2024-02-16
Brief Title:
Exploration of the Optimal Dosage of Cetirizine in the Treatment of Allergic Diseases in Chinese Children
Sponsor:
Peking University Third Hospital
Organization:
Peking University Third Hospital
Organization Data
Organization:
Peking University Third Hospital
Class:
OTHER
Study ID:
PUTH PD_V 12
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Peking University Third Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Dongyang Liu
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Peking University Third Hospital
Old Name:
None
Old Organization:
None